What is Aplindore used for?

Aplindore is being researched as a possible treatment for Parkinson disease and restless legs syndrome.

Is Aplindore approved for use?

No, Aplindore is currently a research compound in Phase 2 clinical trials and is not yet approved for medical use.

Can Aplindore treat Parkinson's disease?

Studies are currently looking into whether Aplindore can help manage Parkinson disease.

Will Aplindore help with restless legs syndrome?

Aplindore is being studied for its potential effectiveness against restless legs syndrome.

What stage of testing is Aplindore in?

Aplindore is currently in Phase 2 of clinical testing.

What kind of drug is Aplindore?

Aplindore is classified as a small molecule drug.

Aplindore | CAS 189681-70-7 | DYJIKHYBKVODAC

Loading compound...

Small molecule research compound

Aplindore is a small molecule drug currently being studied in clinical trials. It is being investigated for its potential use in treating Parkinson disease and restless legs syndrome.

Used for

Parkinson diseaserestless legs syndrome

Conditions

Parkinson diseaserestless legs syndrome

Class

Small moleculeSmall molecule research compoundCentral nervous system

How to take

This drug is currently in the research phase (Phase 2) and is not yet approved for general use by regulatory agencies like the FDA.

Talk to your doctor

Questions to ask

·Is Aplindore being used in any clinical trials I can join?
·How might Aplindore affect my current Parkinson's medications?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-25.

How to take

Talk to your doctor

Frequently asked questions (6)